Faruqi & Faruqi, LLP, a leading securities law firm, is investigating potential claims against SeaStar Medical Holding Corporation (SeaStar). The firm alleges that SeaStar made false and misleading statements about its compliance controls, financial controls, and regulatory prospects. The investigation follows SeaStar’s announcement of a restatement of its financial statements for fiscal year 2022 and subsequent interim periods. Investors who suffered losses exceeding $50,000 are encouraged to contact Faruqi & Faruqi to discuss their legal options.
